Recalls & Warnings November 30, 2023 Discover Health, LLC Warned for Promoting CBD Products for Cancer, Epilepsy, & More On November 16, 2023, the FDA issued a Warning Letter to Discover Health, LLC d/b/a Discover CBD and Strain Snobs following a review of the companys websites that found statements about the companys Active CBD Oil Full Spectrum Distillate Cartridge, Active CBD Oil
10.1152/physrev.00011.2017 Physiol
Formation of the NFT radical anion is required for Nrf2 activation As activation of Nrf2 requires the oxidation of critical sulfhydryl groups in its interaction partner, Keap1, we investigated the mechanism of this activation by NFT
The evidence is clear: for most patients, high-dose oral supplements are as effective as injections
and PT-141, marketed for low libido
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer